BCL2 and neoplasm: In this context, our findings support a model in which PMAIP1 can promote mitochondrial apoptosis via the Bax/Bcl‐2 axis and ROS‐mediated dysfunction in vitro, but its clinical link to poor outcomes reflects context‐dependent regulation within the tumor microenvironment.